GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome

Blood

Volumn 101, Issue 11, 2003, Pages 4301-4304

  Hitzler, Johann K ^a   Cheung, Joseph ^b   Li, Yue ^b   Scherer, Stephen W ^b   Zipursky, Alvin ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR GATA 1; DNA BINDING PROTEIN; ERYTHROID SPECIFIC DNA BINDING FACTOR; GATA1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INFANT; LEUKEMIA; MALE; NEWBORN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REMISSION; SEQUENCE ANALYSIS; ACUTE NONLYMPHOCYTIC LEUKEMIA; CELL CLONE; CELL TRANSFORMATION; GENETICS; MUTATION;

CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; DOWN SYNDROME; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; FEMALE; GATA1 TRANSCRIPTION FACTOR; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; MALE; MUTATION; TRANSCRIPTION FACTORS;

EID: 0038142350     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0013     Document Type: Article

References (25)

1. Fong CT, Brodeur GM. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genet Cytogenet. 1987;28:55-76.
2. Robison LL. Down syndrome and leukemia. Leukemia. 1992;6(suppl 1):5-7.
3. Robison LL, Nesbit ME Jr, Sather HN, et al. Down syndrome and acute leukemia in children: a 10-year retrospective survey from Childrens Cancer Study Group. J Pediatr. 1984;105:235-242.
4. Bennett JM, Catovsky D, Daniel MT, et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:460-462.
5. Zipursky A, Poon A, Doyle J. Leukemia in Down syndrome: a review. Pediatr Hematol Oncol 1992;9:139-149.
6. Zipursky A. Transient leukemia - a benign form of leukemia in newborn infants with trisomy 21. Br J Haematol. 2003;120:930-938.
7. Gamis AS, Hilden JM. Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia? J Pediatr Hematol Oncol. 2002;24:2-5.
8. Taub JW, Ravindranath Y. Down syndrome and the transient myeloproliferative disorder: why is it transient? J Pediatr Hematol Oncol. 2002;24:6-8.
9. Zipursky A, Brown E, Christensen H, Doyle J. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down Syndrome. Clin Lab Med. 1999;19:157-167.
10. Lu G, Altman AJ, Benn PA. Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several? Cancer Genet Cytogenet. 1993;67:81-89.
11. Homans AC, Verissimo AM, Vlacha V. Transient abnormal myelopoiesis of infancy associated with trisomy 21. Am J Pediatr Hematol Oncol. 1993;15:392-399.
12. Hattori M, Fujiyama A, Taylor TD, et al. The DNA sequence of human chromosome 21. Nature. 2000;405:311-319.
13. Gilliland DG, Tallman MS. Focus on acute leukemias. Cancer Cell 2002;1:417-420.
14. Cantor AB, Orkin SH. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene. 2002;21:3368-3376.
15. Shivdasani RA. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells. 2001;19:397-407.
16. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. Embo J. 1997;16:3965-3973.
17. Vyas P, Ault K, Jackson CW, Orkin SH, Shivdasani RA. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood. 1999;93:2867-2875.
18. Zipursky A, Vanek W, Grunberger T, et al. A megakaryoblast cell line from a patient with Down Syndrome-Acute megakaryoblastic leukemia (DS-AMKL): in vitro differntiation of megakaryoblasts [abstract]. Blood. 1993;82(suppl 1):122A.
19. Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32:148-152.
20. Athale UH, Razzouk BI, Raimondi SC, et al. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. Blood. 2001;97:3727-3732.
21. Dastugue N, Lafage-Pochitaloff M, Pages MP, et al. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Blood. 2002;100:618-626.
22. Zipursky A, Thorner P, De Harven E, Christensen H, Doyle J. Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome. Leuk Res. 1994;18:163-171.
23. Honda F, Punnett H, Charney E, Miller G, Thiede H. Serial cytogenetic and hematologic studies on a mongel with trisomy 21 and acute congenital leukemia. J Pediatr. 1964;65:880-887.
24. Duflos-Delaplace D, Lai JL, Nelken B, Genevieve F, Defachelles AS, Zandecki M. Transient leukemoid disorder in a newborn with Down syndrome followed 19 months later by an acute myeloid leukemia: demonstration of the same structural change in both instances with clonal evolution. Cancer Genet Cytogenet. 1999;113:166-171.
25. Polski JM, Galambos C, Gale GB, Dunphy CH, Evans HL, Batanian JR. Acute megakaryoblastic leukemia after transient myeloproliferative disorder with clonal karyotype evolution in a phenotypically normal neonate. J Pediatr Hematol Oncol. 2002;24:50-54.